Portfolio company
SENSIMED SA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Sensimed SA develops sensor-equipped contact lenses that monitor ocular volume changes over 24 hours to help ophthalmologists manage glaucoma treatment for patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Glakolens
This company develops sensor-embedded contact lenses that provide continuous intraocular pressure monitoring for patients with glaucoma and ocular hypertension.
G-Metrics
This digital health company develops implantable micro-sensors and monitoring platforms for glaucoma patients and ophthalmologists to manage intraocular pressure.
Rheon Medical SA
This company develops adjustable drainage devices and ocular implants for the surgical treatment of glaucoma in patients.
Bionode
The company develops wearable neuro-modulation devices and gold-trace contact lenses to treat and prevent elevated intraocular pressure in patients with glaucoma.
Azalea Vision
This company develops smart contact lenses with integrated microelectronics to treat patients suffering from vision disorders and light sensitivity.
SpyGlass Pharma, Inc
The company develops an intraocular lens drug delivery system for patients with glaucoma to provide long-term medication during cataract surgery.
Aquesys
This company develops and manufactures ocular implants for glaucoma patients to reduce intraocular pressure through minimally invasive surgical procedures.
Biophta
This company develops self-administered ocular inserts providing seven-day continuous drug release for patients with glaucoma and macular oedema.
